Hoba Therapeutics Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2016

Location

Copenhagen Denmark

Primary Industry

Pharmaceuticals

About

Founded in 2016 and based in Copenhagen, Denmark, Hoba Therapeutics operates as a developer of disease-modifying treatments for patients with neuropathic pain.

Current Investors

Novo Holdings, Borean Innovation, Indaco Venture Partners

Request a demo to show more

Primary Industry

Pharmaceuticals

Sub Industries

Biopharmaceuticals, Pharmaceutical Research & Development

Website

www.hobatherapeutics.com

Company Stage

Series A

Total Amount Raised

Subscriber access only

Financials

Fiscal Year Ended
Revenue (USD)
% Revenue Growth (YoY)
Operating Income (USD)
Operating Margin
EBITDA (USD)
% EBITDA Margin
NET Income (USD)
% Net Margin

31 Mar 2017

(569,068)

(567,569)

(502,337)

31 Mar 2018

(1,157,333)

(1,148,342)

(891,853)

31 Mar 2019

(1,461,954)

(1,451,968)

(1,145,346)

31 Mar 2020

(1,293,735)

(1,282,262)

(1,582,107)

31 Mar 2021

31 Mar 2022

31 Mar 2023

Unlock the recent years of financials and more for Hoba Therapeutics.

Request a demo to see more.

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.